Cargando…

EGFR Pathway Expression Persists in Recurrent Glioblastoma Independent of Amplification Status

SIMPLE SUMMARY: We compared gene expression in matched primary and recurrent glioblastoma samples, with a focus on those harbouring extra copies of the gene called EGFR (amplified samples). Our results show that in the setting of newly diagnosed glioblastoma, EGFR-amplified compared to EGFR non-ampl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dhawan, Andrew, Manem, Venkata S. K., Yeaney, Gabrielle, Lathia, Justin D., Ahluwalia, Manmeet S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913094/ https://www.ncbi.nlm.nih.gov/pubmed/36765632 http://dx.doi.org/10.3390/cancers15030670

Ejemplares similares

OTEH-2. High-dimensional analysis of spatial immune cell heterogeneity in glioblastoma reveals differences between contrast-enhancing and non-contrast-enhancing tumor rims
por: Watson, Dionysios C, et al.
Publicado: (2021)

EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis
por: Talasila, Krishna M., et al.
Publicado: (2013)

EGFR Amplification and Glioblastoma Stem-Like Cells
por: Liffers, Katrin, et al.
Publicado: (2015)

Uncertainty quantification in the radiogenomics modeling of EGFR amplification in glioblastoma
por: Hu, Leland S., et al.
Publicado: (2021)

Therapeutic Injury and Tumor Regrowth: Tumor Resection and Radiation Establish the Recurrent Glioblastoma Microenvironment
por: Silver, Daniel J., et al.
Publicado: (2018)

Recurrent nontuberculous mycobacterial endophthalmitis: a diagnostic conundrum
por: Venkateswaran, Nandini, et al.
Publicado: (2014)

A multicenter, phase II trial of GC1118, a novel anti‐EGFR antibody, for recurrent glioblastoma patients with EGFR amplification
por: Choi, Seung Won, et al.
Publicado: (2023)

EGFR Amplification and IDH Mutations in Glioblastoma Patients of the Northeast of Morocco
por: Senhaji, Nadia, et al.
Publicado: (2017)

A non-hierarchical organization of tumorigenic NG2 cells in glioblastoma promoted by EGFR
por: Al-Mayhani, Talal F, et al.
Publicado: (2019)

Spatial immunosampling of MRI-defined glioblastoma regions reveals immunologic fingerprint of non-contrast enhancing, infiltrative tumor margins
por: Grabowski, Matthew M., et al.
Publicado: (2023)

Defining EGFR amplification status for clinical trial inclusion
por: French, Pim J, et al.
Publicado: (2019)

Screening for EGFR Amplifications with a Novel Method and Their Significance for the Outcome of Glioblastoma Patients
por: Bieńkowski, Michał, et al.
Publicado: (2013)

The miR-183/96/182 cluster is upregulated in glioblastoma carrying EGFR amplification
por: Schneider, Björn, et al.
Publicado: (2022)

The Role of EGFR Amplification in Deep Venous Thrombosis Occurrence in IDH Wild-Type Glioblastoma
por: Kaye, Brandon, et al.
Publicado: (2023)

Radiogenomic analysis of hypoxia pathway is predictive of overall survival in Glioblastoma
por: Beig, Niha, et al.
Publicado: (2018)

Correlation between EGFR Amplification and the Expression of MicroRNA-200c in Primary Glioblastoma Multiforme
por: Serna, Eva, et al.
Publicado: (2014)

Somatic copy number alterations are associated with EGFR amplification and shortened survival in patients with primary glioblastoma
por: Muñoz-Hidalgo, Lisandra, et al.
Publicado: (2019)

Single-cell heterogeneity of EGFR and CDK4 co-amplification is linked to immune infiltration in glioblastoma
por: Walentynowicz, Kacper A., et al.
Publicado: (2023)

Rathke’s cleft cyst presenting with recurrent aseptic meningitis and inflammatory apoplexy: illustrative case
por: Murayi, Roger, et al.
Publicado: (2023)

EGFR-TKIs resistance via EGFR-independent signaling pathways
por: Liu, Qian, et al.
Publicado: (2018)

Therapeutic Efficacy of GC1118, a Novel Anti-EGFR Antibody, against Glioblastoma with High EGFR Amplification in Patient-Derived Xenografts
por: Lee, Kyoungmin, et al.
Publicado: (2020)

SATB2 drives glioblastoma growth by recruiting CBP to promote FOXM1 expression in glioma stem cells
por: Tao, Weiwei, et al.
Publicado: (2020)

Development and validation of genomic predictors of radiation sensitivity using preclinical data
por: Manem, Venkata S. K.
Publicado: (2021)

SerpinB3 drives cancer stem cell survival in glioblastoma
por: Lauko, Adam, et al.
Publicado: (2022)

Amplification of the EGFR gene can be maintained and modulated by variation of EGF concentrations in in vitro models of glioblastoma multiforme
por: William, Doreen, et al.
Publicado: (2017)

Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma
por: Fontanilles, Maxime, et al.
Publicado: (2020)

Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors
por: Knudsen, Arnon Møldrup, et al.
Publicado: (2021)

The missing link? LGMN connects hypoxia and immunosuppression in glioblastoma
por: Mitchell, Jonathan, et al.
Publicado: (2023)

Can Tumor Location on Pre-treatment MRI Predict Likelihood of Pseudo-Progression vs. Tumor Recurrence in Glioblastoma?—A Feasibility Study
por: Ismail, Marwa, et al.
Publicado: (2020)

Next generation sequencing and molecular imaging identify EGFR mutation and amplification in a glioblastoma multiforme patient treated with an EGFR inhibitor: a case report
por: Zhou, Ke, et al.
Publicado: (2017)

Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression
por: Alban, Tyler J., et al.
Publicado: (2020)

Whole genome sequence analysis links chromothripsis to EGFR, MDM2, MDM4, and CDK4 amplification in glioblastoma
por: Furgason, John M., et al.
Publicado: (2015)

An Excellent Clinical Outcome with Stereotactic Radiosurgery in a Geriatric Patient with Multiple and Recurrent Brain Metastases
por: Thapa, Bicky, et al.
Publicado: (2017)

Plasma nanoDSF Denaturation Profile at Baseline Is Predictive of Glioblastoma EGFR Status
por: Eyraud, Rémi, et al.
Publicado: (2023)

Mechanisms of EGFR Resistance in Glioblastoma
por: Pan, Peter C., et al.
Publicado: (2020)

Cancer stem cells in glioblastoma
por: Lathia, Justin D., et al.
Publicado: (2015)

Interrogating the interactions between myeloid derived suppressor cells and cancer stem cells in glioblastoma
por: Otvos, Balint, et al.
Publicado: (2013)

IL-11 drives postsurgical hepatocellular carcinoma recurrence
por: Lauko, Adam, et al.
Publicado: (2019)

Sex-Biased T-cell Exhaustion Drives Differential Immune Responses in Glioblastoma
por: Lee, Juyeun, et al.
Publicado: (2023)

Prognostic impact of CDKN2A/B deletion, TERT mutation, and EGFR amplification on histological and molecular IDH-wildtype glioblastoma
por: Ma, Sirui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_evi2hvedcm0og2afpdn94fg0gr